NCT00041457

Brief Summary

To evaluate potentially modifiable lifestyle predictors of venous thromboembolism and their joint associations with biochemical and genetic determinants.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Jul 2002

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2002

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

July 8, 2002

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 9, 2002

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2006

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2006

Completed
Last Updated

August 7, 2015

Status Verified

August 1, 2015

Enrollment Period

3.9 years

First QC Date

July 8, 2002

Last Update Submit

August 5, 2015

Conditions

Cardiovascular DiseasesThromboembolismPeripheral Vascular Diseases

Study Arms (4)

Physicians' Health Study I

Physicians' Health Study II

Women's Health Study

Women's Antioxidant Cardiovascular Health Study

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
No human subjects are involved. Collected data are used.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Related Publications (2)

  • Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ; PREVENT Investigators. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med. 2003 Apr 10;348(15):1425-34. doi: 10.1056/NEJMoa035029. Epub 2003 Feb 24.

    PMID: 12601075BACKGROUND

  • Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol. 2005 Nov 15;162(10):975-82. doi: 10.1093/aje/kwi309. Epub 2005 Oct 5.

    PMID: 16207808BACKGROUND

MeSH Terms

Conditions

Cardiovascular DiseasesThromboembolismPeripheral Vascular Diseases

Condition Hierarchy (Ancestors)

Embolism and ThrombosisVascular Diseases

Study Officials

  • Robert Glynn

    Brigham and Women's Hospital

Study Design

Study Type
observational
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Biostatistician; Professor of Medicine

Study Record Dates

First Submitted

July 8, 2002

First Posted

July 9, 2002

Study Start

July 1, 2002

Primary Completion

June 1, 2006

Study Completion

June 1, 2006

Last Updated

August 7, 2015

Record last verified: 2015-08